Yangzhou Aurite Pharmaceutical

Yangzhou Aurite Pharmaceutical is a specialized manufacturer of active pharmaceutical ingredients (APIs) and advanced intermediates, operating as a key subsidiary of the publicly listed Aurite Pharmaceutical Co., Ltd. The company is recognized for its expertise in the complex synthesis of steroid hormones, respiratory medications, and cardiovascular treatments. Its state-of-the-art facilities in Yangzhou are designed to comply with international regulatory standards, including US FDA and EU GMP requirements, facilitating exports to highly regulated global markets. Beyond its internal product portfolio, the company provides comprehensive CDMO services, supporting global pharmaceutical clients from process development through to commercial-scale production. Yangzhou Aurite plays a critical role in the parent company's supply chain, focusing on high-value, complex small molecule chemistry and fermentation technologies.